02071... 02071837965 Reveal phone no. >
Shameer Mehta: Consultant Gastroenterologist in London
Dr Shameer Mehta is an experienced and highly qualified Consultant Gastroenterologist at University College London Hospital. He is also available for private consultations at The London Gastroenterology Centre on Welbeck Street.
A renowned specialist with a particular focus on clinical nutrition and inflammatory bowel disease, Dr Mehta offers comprehensive treatment for dyspepsia, reflux disorders and a wide range of other gastrointestinal conditions.
Training and education
Dr Mehta obtained his primary medical qualification from the University of London, from which he graduated in 2003 with a Bachelor in Medicine and Surgery, having previously obtained a Bachelors in Science with honours in Molecular Medicine.
He subsequently went on to undertake an advanced training programme at three different London teaching hospitals. From this he gained experience in the management of patients with inflammatory bowel disease and intestinal failure. Following this extensive training, Dr Mehta embarked on a joint fellowship in Translational Science Research and Medical Education from the Blizard Institute and Queen Mary University in London.
Not long after, he was appointed Consultant Gastroenterologist at University College London Hospital, where he works within the highly-specialised Intestinal Failure Unit.
Combining both his extensive clinical experience and training, Dr Mehta offers a comprehensive approach to the diagnosis and treatment of gut disorders. He strives to provide his patients with the highest standards of care, working hard to deliver the best patient outcomes across the scope of his practice.
The London Gastroenterology Centre
Dr Mehta is available for consultations at his private practice at The London Gastroenterology Centre. This specialist centre brings together an expert team of gastroenterologists and surgeons who specialise in diagnosing and treating gut disorders in world class private hospitals and clinics in central London and Harley Street.
Gastroenterology treatments in London
- Reflux disorders
- Functional gut disorders e.g. Irritable Bowel Disorders
- General gastrointestinal conditions
High standards of patients care
Putting patient care at the heart of all that he does, Dr Mehta has been instrumental in helping to improve the patient’s experiences when taken ill, across four major London Hospitals. His patient centric approach allows him the unique opportunity to not only ensure that his patients are in control of their treatment, but also that their care is tailored to their individual needs.
Initial consultation: £245
Follow up consultation: £200
Dr Mehta is actively involved in researching the role of microRNAs in the development of intestinal fibrosis in Crohn’s disease. He has presented his research at numerous international conferences and continues to be involved with clinical trials to help advance the management of his patients. His research is close to completion.
Dr Mehta has published a number of papers, including:
- Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype. Lewis A, Mehta S, Hanna LN, Rogalski LA, Jeffery R, Nijhuis A, Kumagai T, Biancheri P, Bundy JG, Bishop CL, Feakins R, Di Sabatino A, Lee JC, Lindsay JO, Silver A. Inflamm Bowel Dis 2015; 21(8): 1926-34
- Defects in the adherens junction complex in inflammatory colorectal disease. Mehta SJ, Nijhuis A, Kumagai A, Lindsay JO, Silver AR. Cell Tissue Res. 2015; 360(3): 749-60
- Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets. Mehta SJ, Nijhius A, Kumagai T, Lewis A, Lindsay JO, Silver AR . Inflamm Bowel Dis 2015; 21(5): 1141-50
- Strategies for the Management of Chronic Unremitting Ulcerative Colitis. Mehta SJ, Silver AR, Lindsay JO. Aliment Pharmacol Ther 2013; 38(2): 77-97
- Peripheral arterial thrombosis associated with the use of infliximab in a patient with Crohn’s Disease. Mehta SJ, Berger J, Tang KH. Grand Rounds 2010; 10: 78-81
- Smoking cessation may improve the microbial flora profile. Mehta SJ. Thorax 2007; 62: 676
- The integrin is expressed in breast cancer and promotes a migratory phenotype in breast carcinoma cells. Mehta SJ, Dublin E, Meyer T, Thomas GJ, Hanby A, Hart IR, Marshall JF. Seminars in Metastasis, Metastasis Research Society, 2000
Book an appointment
02071... 02071837965 Reveal phone no. >
incom... email@example.com revealBook a consultation now
Qualified in 2003 in United Kingdom
Registrations and licensing
General Medical Council (GMC)
Registration no.: 6077083 Date of registration: 04-Aug-2004